Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$48,511,571
-$15,789,837 QoQ
Shares Held
191,013
-27.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.01%
of 13F equity value
Holder Rank
#448
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RNC CAPITAL MANAGEMENT LLC holds $281,592,319 across 11 Drug Manufacturers - General names. JNJ ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
517,240 | $66,465,340 | |
| 2 | ABBV |
AbbVie Inc.
|
236,727 | $59,569,982 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
191,013 | $48,511,571 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
356,290 | $45,013,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
645,383 | $37,186,968 | |
| 6 | LLY |
ELI LILLY & Co
|
13,549 | $16,251,078 | |
| 7 | AZN |
Astrazeneca PLC
|
32,535 | $6,169,286 | |
| 8 | AMGN |
Amgen Inc
|
2,755 | $997,640 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,511,571 | 191,013 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $64,301,408 | 263,056 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $57,431,729 | 277,515 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $50,985,864 | 274,975 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,339,397 | 277,181 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $46,043,817 | 277,640 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $33,394,782 | 230,914 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $46,051,941 | 284,166 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $41,533,702 | 284,166 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $43,660,756 | 276,002 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $43,380,773 | 276,769 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $46,393,564 | 297,872 | Shares | Sole | 2023-12-27 | |
| 2023-06-30 | $42,872,824 | 259,019 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $40,021,930 | 258,206 | Shares | Defined | 2023-04-21 | |
| 2022-12-31 | $36,537,579 | 206,836 | Shares | Defined | 2023-01-11 | |
| 2022-09-30 | $33,943,757 | 207,785 | Shares | Defined | 2022-10-18 | |
| 2022-06-30 | $37,648,983 | 212,095 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $38,107,462 | 215,017 | Shares | Defined | 2022-07-22 | |
| 2021-12-31 | $37,928,613 | 221,714 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $34,906,287 | 216,138 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $35,880,701 | 217,802 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $34,611,945 | 210,599 | Shares | Defined | 2021-04-26 | |
| 2020-12-31 | $32,604,729 | 207,172 | Shares | Defined | 2021-01-13 | |
| 2020-09-30 | $31,007,386 | 208,271 | Shares | Defined | 2020-12-03 | |
| 2020-06-30 | $30,016,207 | 213,441 | Shares | Defined | 2020-07-23 | |
| 2020-03-31 | $29,572,306 | 225,519 | Shares | Defined | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||